Table 2. SAR of Lactam Pyrazolopyrimidines 18–21.
Cmpda | * | R | R′ | PI3Kδ SPA IC50 (nM) | SU-DHL-6 Viability IC50 (nM) | Pfeiffer Proliferation IC50 (nM) | Pfeiffer PBadj IC50 (nM) | % fu in human plasma | IntCL (L/h/kg) | Caco2 Pm (×10–6 cm/s) |
---|---|---|---|---|---|---|---|---|---|---|
18 | Me | Me | 2.4 | 13 | 51 | 480 | 10 | 0.7 | 2.8 | |
19 | Me | Et | 1.4 | 2.1 | 4.8 | 47 | 6.5 | 0.7 | 1.9 | |
20 | R | F | Et | <1.0 | 1.6 | 2.5 | 4.2 | 5.8 | 0.7 | 1.0 |
21 | CN | Et | <1.0 | 0.47 | 1.7 | 4.1 | 23 | 0.7 | 0.3 |
Single isomers. fu = fraction unbound.